BridgeBio Oncology Therapeutics, Inc.
BridgeBio Oncology Therapeutics, Inc.
BridgeBio Oncology Therapeutics, Inc. (BBOT) — SEC Financial Statements & Analysis
BridgeBio Oncology Therapeutics, Inc. (BBOT) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Related Party | - | - | - | 0 | 0 | 0 | - | - | - | |||||
Common Class A | - | - | - | 0 | 19 | 18 | 18 | 0 | 1 | |||||
Common Class B | - | - | - | 0 | 5 | 0 | 0 | 0 | 5 | |||||
Preferred Stock | 0 | 0 | 0 | - | 0 | 23 | 36 | - | - | |||||
Assets Current | ||||||||||||||
Assets | ||||||||||||||
Cash And Cash Equivalents At Carrying Value | 53 | 374 | 409 | 1 | 1 | 31 | 2 | 2 | 2 | |||||
Prepaid Expense Current | - | - | - | - | - | - | - | 0 | 0 | |||||
Prepaid Taxes | - | - | - | - | 0 | 0 | 0 | - | - | |||||
Marketable Securities Current | 200 | 52 | 60 | - | - | 125 | - | - | - | |||||
Accounts And Other Receivables Net Current | 0 | 0 | - | - | - | 0 | - | - | - | |||||
Prepaid Expense And Other Assets Current | 14 | 7 | 7 | 0 | - | 3 | - | - | - | |||||
Prepaid Insurance | - | - | - | 0 | 0 | 0 | 0 | - | - | |||||
Assets Current | 267 | 432 | 476 | 1 | 1 | 159 | 2 | 2 | 2 | |||||
Prepaid Expense Noncurrent | - | - | - | - | - | - | - | - | 0 | |||||
Assets Held In Trust Noncurrent | - | - | - | 197 | 194 | 192 | 190 | 188 | 185 | |||||
Marketable Securities Noncurrent | 137 | - | - | - | - | - | - | - | - | |||||
Property Plant And Equipment Net | 1 | 1 | 1 | - | - | 0 | - | - | - | |||||
Operating Lease Right Of Use Asset | 2 | 2 | 2 | - | - | 0 | - | - | - | |||||
Other Assets Noncurrent | 11 | 13 | 5 | - | - | 5 | - | - | - | |||||
Restricted Cash Noncurrent | 0 | 0 | 0 | - | - | 0 | - | - | - | |||||
Assets | 418 | 448 | 485 | 197 | 196 | 164 | 192 | 190 | 188 | |||||
Liabilities And Stockhold… | ||||||||||||||
Accrued Liabilities Current | - | - | - | - | 2 | 0 | 0 | 0 | 0 | |||||
Liabilities Current | ||||||||||||||
Accounts Payable And Accrued Liabilities Current | - | - | - | 3 | - | - | - | - | - | |||||
Accounts Payable Current | 12 | 1 | 4 | - | - | 3 | - | - | - | |||||
Accrued Employee Benefits Current | 2 | 6 | 4 | - | - | 4 | - | - | - | |||||
Accrued Professional Fees Current | 1 | 1 | 2 | - | - | 1 | - | - | - | |||||
Notes Payable Current | 1 | 1 | 1 | - | - | 0 | - | - | - | |||||
Operating Lease Liability Current | 1 | 1 | 1 | - | - | 0 | - | - | - | |||||
Other Accrued Liabilities Current | 1 | 0 | 0 | - | - | 0 | - | - | - | |||||
Participating Mortgage Loans Participation Liabili… | - | 0 | - | - | - | 3 | - | - | - | |||||
Liabilities Current | 43 | 35 | 36 | 3 | 2 | 20 | 0 | 0 | 0 | |||||
Deferred Compensation Liability Classified Noncurr… | - | - | - | - | - | - | - | - | 6 | |||||
Operating Lease Liability Noncurrent | 2 | 2 | 2 | - | - | 0 | - | - | - | |||||
Liabilities | 45 | 37 | 38 | 8 | 7 | 20 | 6 | 6 | 6 | |||||
Temporary Equity Carrying Amount Attributable To P… | - | - | - | - | - | - | - | - | 185 | |||||
Stockholders Equity | ||||||||||||||
Common Stock Value | 0 | 0 | 0 | - | - | 0 | - | - | 0 | |||||
Additional Paid In Capital | 772 | 768 | 764 | - | - | 44 | - | - | - | |||||
Retained Earnings Accumulated Deficit | -399 | -357 | -318 | -7 | -6 | -223 | -4 | -3 | -3 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -1 | 0 | 0 | - | - | 0 | - | - | - | |||||
Stockholders Equity | 372 | 411 | 447 | -7 | -200 | -179 | -159 | -3 | -3 | |||||
Liabilities And Stockholders Equity | 418 | 448 | 485 | 197 | 196 | 164 | 192 | 190 | 188 | |||||
Redeemable Convertible Preferred Stock | 0 | 0 | 0 | - | 36 | 36 | 36 | - | - | |||||
Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 0 | 5 | 5 | 5 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | - | - | 0 | - | - | - | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | - | - | 0 | - | - | - | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | - | - | 0 | - | - | - | |||||
Common Stock Shares Authorized | 500 | 500 | 500 | - | - | 496 | - | - | - | |||||
Common Stock Shares Issued | 80 | 80 | 79 | - | - | 57 | - | - | - | |||||
Shares Outstanding | 80 | 80 | 79 | - | - | 57 | - | - | - | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -3.94% | -0.25% | - | - | - | - | - | - | - | - | - | - |
| 2025 | 0.37% | -1.94% | -3.83% | -15.28% | 9.45% | 6.86% | 8.39% | -2.69% | -7.21% | -10.21% | -11.22% | -13.55% |
| 2024 | -0.77% | -1.26% | 0.48% | 0.05% | 0.24% | 1.83% | -0.71% | 4.42% | 1.66% | 1.03% | 1.50% | 0.47% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data